TradingView
intelitrades
Nov 10, 2019 3:47 PM

A Short To Consider Short

Adverum Biotechnologies, Inc.NASDAQ

Description

Shrinking revenues and increasing costs, YOY: seekingalpha.com/symbol/ADVM/income-statement

Better products from much larger competitors: seekingalpha.com/news/3505590-adverum-regenxbio-go-opposite-ways-wet-amd-data

EV/EBITDA: -5
EPS: -1
Up 176% for the year

Might be worth targeting a 30% decline in the mid term? Thoughts?
More